The high cost of delay: Study reveals health and financial risks of missed HepB vaccine

This week the Advisory Committee on Immunization Practices (ACIP) will consider delaying the infant hepatitis B (HepB) birth dose vaccine schedule. However, new research from Portland State University shows that even a short delay can lead to…

Continue Reading

News Source: medicalxpress.com